Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a cancer of the white blood cells. It is a form of leukemia characterized...
34 KB (3,877 words) - 13:44, 25 October 2024
Accelerated phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which the disease is progressing. Common symptoms include...
2 KB (151 words) - 19:57, 17 July 2024
Primary myelofibrosis (redirect from Chronic idiopathic myelofibrosis)
Media, LLC. pp. 28–. ISBN 978-0-387-73744-7. Karp JE (2007). Acute myelogenous leukemia. Humana Press. pp. 385–. ISBN 978-1-58829-621-4. Retrieved 13 November...
27 KB (2,844 words) - 13:15, 3 August 2024
the term "acute leukemia" in 1889 to differentiate rapidly progressive and fatal leukemias from the more indolent chronic leukemias. The term "myeloid"...
75 KB (7,543 words) - 03:11, 2 November 2024
stain of chronic myelogenous leukemia in accelerated phase (blast crisis) Wolach, O; Stone, R. M. (2015). "How I treat mixed-phenotype acute leukemia". Blood...
5 KB (457 words) - 04:55, 24 September 2024
in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia". Blood. 111 (4): 1834–1839. doi:10.1182/blood-2007-04-083196...
43 KB (5,251 words) - 10:44, 24 June 2024
List of hematologic conditions (section Leukemia)
Central: 6. doi:10.1186/1752-1947-3-6. PMC 2627909. PMID 19126231. "Leukemia - Chronic Lymphocytic - CLL". Cancer.Net. American Society of Clinical Oncology...
70 KB (2,582 words) - 03:15, 16 December 2023
medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Specifically it is used to treat cases...
22 KB (1,994 words) - 08:45, 4 November 2024
Musashi-2 (section Chronic myelogenous leukemia)
Chronic myelogenous leukemia (CML) progresses from the initial phase, where differentiated myeloid cells are accumulated, to the accelerated phase, where...
13 KB (1,672 words) - 00:55, 19 September 2024
used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well...
20 KB (1,697 words) - 00:44, 27 August 2024
449 patients treated during 4 years with ponatinib for chronic phase chronic myelogenous leukemia found the following adverse reactions. 150 Patients experienced...
20 KB (1,623 words) - 12:42, 5 August 2024
Hematological Leukemias Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Chronic lymphocytic leukemia (CLL) Chronic myelogenous leukemia (CML)...
4 KB (364 words) - 18:31, 9 February 2024
Lysozyme Inflammation Inflammatory reflex Inflammasome Granuloma Acute-phase proteins Amyloid SAP SAA Positive Alpha 1-antichymotrypsin Alpha 1-antitrypsin...
38 KB (2,656 words) - 20:26, 6 November 2024
blast crisis of chronic myelogenous leukemia and is proposed to play a role in the transformation of the chronic and/or accelerated phases of this disease...
34 KB (4,038 words) - 23:30, 21 June 2024
leukemia – chronic myelogenous leukemia – chronic myeloid leukemia – chronic myelomonocytic leukemia – chronic phase – chronic phase chronic myelogenous leukemia...
69 KB (5,119 words) - 11:20, 3 June 2024
genetic lesion found commonly in chronic myelogenous leukemia and in some patients with acute lymphoblastic leukemia. This fusion protein has enzyme activity...
155 KB (17,518 words) - 23:36, 26 October 2024
most successful treatment for Philadelphia chromosome-positive chronic myelogenous leukemia (CML) and certain other diseases. More recently, the FDA approved...
26 KB (3,221 words) - 19:23, 19 August 2024
FIRM PLANS IND THIS AUTUMN FOR SYSTEMIC ANTISENSE PRODUCT FOR CHRONIC MYELOGENOUS LEUKEMIA". Medtech Insight. August 19, 1991. Retrieved 7 December 2019...
30 KB (3,528 words) - 05:06, 24 June 2024
University of Pennsylvania (section Coordinated dual-degree, accelerated, interdisciplinary programs)
used to treat acne), Resistin, the Philadelphia gene (linked to chronic myelogenous leukemia) and the technology behind PET Scans were all discovered by Penn...
212 KB (20,057 words) - 05:59, 8 November 2024
Philadelphia chromosome-positive leukemias (chronic myelogenous leukemia and occasionally acute lymphocytic leukemia). Imatinib is substantially different...
44 KB (5,022 words) - 08:47, 12 October 2024
2012, the FDA approved bosutinib (Bosulif) for chronic myelogenous leukemia (CML), a rare type of leukemia and a blood and bone marrow disease that affects...
168 KB (14,575 words) - 17:46, 20 October 2024
design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia". Annals of the New York Academy of Sciences. 1028 (1): 423–31...
85 KB (9,213 words) - 15:00, 28 October 2024
1983). "Isolation and characterization of gangliosides from chronic myelogenous leukemia cells". Cancer Research. 43 (12 Pt 1): 5890–5894. PMID 6580065...
296 KB (31,942 words) - 21:22, 28 August 2024
chromosome, or translocation of chromosomes 9 and 22, which occurs in chronic myelogenous leukemia, and results in production of the BCR-abl fusion protein, an...
115 KB (13,952 words) - 04:56, 2 November 2024
giant cell tumours of the soft tissue: A dose-escalation and dose-expansion phase 1 study". The Lancet Oncology. 16 (8): 949–956. doi:10.1016/S1470-2045(15)00132-1...
96 KB (492 words) - 17:19, 10 November 2024
Trujillo J, Keating M, Gutterman JU (February 1987). "Therapy of chronic myelogenous leukemia". Cancer. 59 (3 Suppl): 664–7. doi:10.1002/1097-0142(1987020...
28 KB (3,327 words) - 19:25, 25 July 2024